Life Healthcare Group Holdings has entered into binding agreements for the sale of Life Molecular Imaging, a member of the Imaging Group, subject to receipt of shareholders and various regulatory and other approvals. Life Healthcare is part of the group that acquired Piramal Imaging SA from Piramal Enterprises in 2018.
The company stated that it will become eligible to receive an estimated amount of $140 million, expected to be received in FY26. It may also receive further amounts in subsequent years from any eligible profits and future earnouts relating to the Imaging Group, subject to a maximum of $200 million (inclusive of the above $140 million).
Piramal Enterprises (PEL) is a leading diversified NBFC in India with a presence across retail lending, wholesale lending, and fund-based platforms. The company has investments and assets worth around $10 billion, with a network of branches across 26 states/UTs.
The NBFC reported a 238.2% surge in consolidated net profit to Rs 162.97 crore on a 9.2% rise in total income to Rs 2,486.18 crore in Q2 FY25 over Q2 FY24.